Publication Name	World Journal of Clinical Cases
Manuscript ID	77447
Country	Malaysia

Received	2022-04-30 16:35
Peer-Review Started	2022-04-30 16:38
To Make the First Decision
Return for Revision	2022-05-30 01:36
Revised	2022-06-13 04:10
Second Decision	2022-09-22 03:44
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-09-23 00:35
Articles in Press	2022-09-23 00:35
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-09-20 16:27
Typeset the Manuscript	2022-10-10 03:25
Publish the Manuscript Online	2022-10-21 02:24

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Role of visfatin in obesity-induced insulin resistance
Manuscript Source	Invited Manuscript
All Author List	Mona Mohamed Ibrahim Abdalla
ORCID	Author(s) ORCID Number Mona Mohamed Ibrahim Abdalla http://orcid.org/0000-0002-4987-9517
Funding Agency and Grant Number
Corresponding Author	Mona Mohamed Ibrahim Abdalla, MSc, PhD, Senior Lecturer, Physiology Department, Human Biology Division, School of Medicine, International Medical University, No. 126, 19 Jln Jalil Perkasa, Kuala Lumpur 57000, Bukit Jalil, Malaysia. monamohamed@imu.edu.my
Key Words	Homeostatic model assessment for insulin resistance; Insulin resistance; Obesity; Visfatin; pre-B cell colony enhancing factor; Nicotinamide phosphoribosyltransferase enzyme; Diabetes; Adipocytokines
Core Tip	Visfatin is an adipocytokine that is produced by visceral fat and other sources. It has been shown to influence glucose and lipid metabolism, as well as enhance the chronic inflammatory state linked to obesity. The findings on the relationship between visfatin and IR in obese patients are controversial. This review aims to better understand how visfatin contributes to the emergence of IR and to assess the possibility of utilizing visfatin levels as a biomarker for the early detection of IR and IR-related diseases, including cardiovascular and renal diseases.
Publish Date	2022-10-21 02:24
Citation	Abdalla MMI. Role of visfatin in obesity-induced insulin resistance. World J Clin Cases 2022; 10(30): 10840-10851
URL	https://www.wjgnet.com/2307-8960/full/v10/i30/10840.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i30.10840

Full Article (PDF)	WJCC-10-10840.pdf
Full Article (Word)	WJCC-10-10840.docx
Manuscript File	77447_Auto_Edited-YLC-Kerr C-JLW.docx
Answering Reviewers	77447-Answering reviewers.pdf
Audio Core Tip	77447-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	77447-Conflict-of-interest statement.pdf
Copyright License Agreement	77447-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	77447-Language certificate.pdf
Peer-review Report	77447-Peer-review(s).pdf
Scientific Misconduct Check	77447-Bing-Chen YL-2.png
Scientific Editor Work List	77447-Scientific editor work list.pdf